Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

about

Commentary on tumor heterogeneity.Liquid Biopsy in Tumor Genetic Diagnosis.Characterization of Factors Affecting the Detection Limit of EGFR p.T790M in Circulating Tumor DNA

P2860

Q42398711-C5027D94-A90A-4353-A852-C6EF80CE7828 Q55285184-CBD1012E-8EC3-4468-9760-85B8C32F8D06 Q58786657-D0A661E8-1E2E-4C01-A0D2-DAC7E5DBD9D3

P2860

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

Item

http://www.wikidata.org/entity/Q42398713

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@en

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@nl

type

Item

label

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@en

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@nl

prefLabel

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@en

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@nl

P1476

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

@en

P2093

Mari Mino-Kenudson

http://www.w3.org/2001/XMLSchema#string

P2860

Circulating microRNAs as stable blood-based markers for cancer detection.

Tumor self-seeding by circulating cancer cells

Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

Cell-free nucleic acids as biomarkers in cancer patients.

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients.

Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA

Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients.

Circulating nucleic acids (CNAs) and cancer--a survey.

Tissue-specific and plasma microRNA profiles could be promising biomarkers of histological classification and TNM stage in non-small cell lung cancer.

P304

424-427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.21037/TLCR.2016.08.01

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27655060

http://www.w3.org/2001/XMLSchema#string

P932

5009080

http://www.w3.org/2001/XMLSchema#string

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

about

P2860

P2860

Cons: Can liquid biopsy replace tissue biopsy?-the US experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932